Skeletal metastases in pancreatic cancer: A retrospective study and review of the literature

Yale Journal of Biology and Medicine

Volumn 82, Issue 1, 2009, Pages 1-6

  Borad, Mitesh J ^a,b   Saadati, Hamid ^c   Lakshmipathy, Arun ^b   Campbell, Elizabeth ^a,b   Hopper, Patricia ^b   Jameson, Gayle ^b   Von Hoff, Daniel D ^a,b,d   Saif, M Wasif ^c,e  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b Scottsdale Clinical Research Institute   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF ARIZONA   (United States)

^e Division of Medical Oncology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE;

ADULT; AGED; BONE MARROW; BONE METASTASIS; CANCER SURVIVAL; CLINICAL ARTICLE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; PANCREAS CANCER; REVIEW; SPINE METASTASIS;

ADENOCARCINOMA; AGED; BONE NEOPLASMS; COMORBIDITY; CONNECTICUT; HUMANS; INCIDENCE; MIDDLE AGED; PANCREATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS;

EID: 64949143741     PISSN: 00440086     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (28)

1. Wafflart E, Gibaud H, Lerat F, et al. Muscular metastases of cancer of the pancreas. J Chir. 1996;133(4):167-70.
2. Otegbayo JA, Oluswasola OA, Akere A, et al. Pancreatic carcinoma presenting as cutaneous nodules in a diabetic Nigerian male. West Afr J Med. 2005;24(2):180.
3. Robinson BW, Lewis RR. Myocardial metastases from carcinoma of pancreas presenting as acute myocardial infarction. JR Soc Med. 1982;75(7):560-62.
4. Turiaf J, Battesti JP, Basset F, et al. Metastatic pleurisy in pancreatic cancer with the presence of considerable quantities of amylase in the pleural effusion and a major paraneoplastic peripheral neurologic syndrome. Ann Med Interne. 1969;120(6):449-58.
5. Takamori H, Kanemitsu K, Tsuji T, et al. Metastatic gastric tumor secondary to pancreatic adenocarcinoma. J Gastroenterol. 2005;40(2):209-12.
6. Crescentini F, Deutsch F, Sobrado CW, et al. Umbilical mass as the sole presenting symptom of pancreatic cancer: a case report. Rev Hosp Clin Fac Med Sao Paulo. 2004;59(4):198-202.
7. Martino L, Martino F, Coluccio A, et al. Renal metastases from pancreatic adenocarcinoma. Arch ItalUrolAndrol. 2004;76(l):37- 9.
8. Filik L, Ozdal-Kuran S, Cicek B, et al. Appendicular metastases from pancreatic adenocarcinoma. Int J Gastrointest Cancer. 2003;34(l):55-8.
9. Bandyopadhyay D, Kapadia CR, Da Costa PE. Pancreatic carcinoma: report of two cases presenting with unusual metastases. Indian J Gastroenterol. 2005;24(2):75-6.
10. Merseburger AS, Muller CC, Merseburger Schonborn CT, et al. A rare case of isolated prostate metastasis from primary pancreatic cancer. Urologe A. 2005;44(5):527-9.
11. Lipko AA. Features of the course of lung and bone metastases of pancreatic cancer. Vopr Onkol. 1963;92:80-5.
12. Hatfield DR, Leland FH, Maruyama Y. Skeletal metastases in pancreatic carcinoma: Study by Isotopic bone scanning. Oncology. 1976;33(l):44-7.
13. Iguchi H, Yasuda M, Matsuo T, Samii T, Funakoshi A. Clinical features and management of pancreatic cancer with bone metastases. Nippon Shokakibyo Gakkai Zasshi. 2004;101(8):872-8.
14. Tamm E, Charnsangavej C. Pancreatic Cancer: Current concepts in imaging for diagnosis and staging. Cancer J. 2001;7:298-311.
15. Gillison EW, Grainger RG, Fernandez D. Osteoblastic metastases in carcinoma of Pancreas. Br JRadiol. 1970;43(515):818-20.
16. Hatfield DR, Leland FH, Maruyama Y Skeletal metastases in Pancreatic Carcinoma: Study by Isotopic bone scanning. Oncology. 1976;33(l):44-7.
17. Joffe N, Antonioli DA. Osteoblatic bone metastases secondary to Adenocarcinoma of the Pancreas. Clin Radiol. 1978;29(l):41-6.
18. Nishiyama Y, Yamamoto Y, Yokoe K, et al. Contribution of Whole body FDG-PET to the detection of distant metastases in pancreatic cancer. Ann Nucl Med. 2005;19(6):491-7.
19. Sperti C, Pasquali C, Chierichetti F, et al. 18- Fluorodeoxyglucose positron emission tomography in predicting survival in patients with pancreatic carcinoma. J Gastrointest Surg. 2003;7:953-9.
20. Lytras D, Connor S, Bosonnet L, et al. Positron Emmision Tomography does not add to the Computer Tomography for the diagnosis and staging of Pancreatic Cancer. Dig Surg. 2005;22(l-2):55-61.
21. Lyons JD, Alibazoglu B, Harris JE, Ali A, Hollinger EF. Pelvic metastases from pancreatic carcinoma: a pattern observed on bone scan. Clin Nucl Med. 2001;26(3):230-l.
22. Wu CH, Kaga K, Ohira Y, Suzuki J. Histopathology of temporal bone metastases from Pancreatic Adenocarcinoma: A case showing bilateral hearing loss and Bechterew's phenomenon. Otolaryngol Head Neck Surg. 2000;122(4):613-5.
23. Ohira Y, Kaga K, Kodama A. Acase of bilateral sudden hearing loss and vertigo caused by bilateral temporal metastases from Pancreatic Carcinoma-comparison of clinical findings and temporal bone pathological findings. Nippon Jibiinkoka Gakkai Kaiho. 1991;94(1):9-15.
24. Kakonen SM, Mundy GR. Mechanisms of Osteolytic bone metastases in breast carcinoma. Cancer. 2003;97(3):834-9.
25. Schmitz-Winnenthal FH, Volk C, et al. High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients. Cancer Res. 2005;65(21):10079-87.
26. Burris HA, Moore MJ, Anderson J, et al. Improvement in survival and clinical cancer. A Randomized benefit with Gemcitabine as first line therapy for patients with advanced pancreas trial. J Clin Oncol. 1997;15:2403- 13.
27. Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared to gemcitabine alone in patients with advanced pancreatic cancer. A Phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 2007;25(15):1960-6.
28. Clezarin P, Ebetino FH, Fournier PG. Bisphosphonates and cancer-induced bone disease: beyond their antiresorptive activity. Cancer Res. 2005;65(12):4971-4.